Blood biomarkers for AD currently include Aβ42/Aβ40 ratio [62], hyperphosphorylated tau forms (p-Tau 181, p-Tau 217, p-Tau 231) [63, 64], and GFAP [22, 33, 65]. Here, MAPT is linked to Alzheimer disease.